The surgical site infection (SSI) market was valued at $4.0 billion in 2017, and it is expected to reach $5.9 billion by 2023, growing at a CAGR of 6.4% during the forecast period of 2018–2023. The key factors helping in this growth include a surge in the incidence of SSIs, increase in the number of surgical procedures, rise in the geriatric population, and development of technologically improved products. Additionally, favorable government regulations will propel the market growth during the forecast period.
Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/surgical-site-infection-market/report-sample
The major reason behind the growth of the market is the increasing volume of surgeries. Such medical procedures are done for therapeutic as well as diagnostic purposes, which is why operating rooms (OR) remain ever-busy. Every surgery, however minimally invasive, requires cutting into the flesh, which leads to wounds. Despite taking place in the cleanest of OR, every surgery carries a risk of infection at the operated-upon site. Therefore, with the increasing incidence of chronic diseases pushing up the surgery volume, the demand for SSI management products is rising too.
Make an Enquiry before Purchase:https://www.psmarketresearch.com/send-enquiry?enquiry-url=surgical-site-infection-market
Considering the regional scenario, North America generated the highest revenue in the surgical site infection market in 2017 due to the growing awareness about SSIs, advanced healthcare sector, and presence of leading market players. These factors, coupled with the increasing number of surgeries and surging elderly population, are propelling the market growth. Moreover, during the forecast period, the Asia-Pacific (APAC) region is projected to showcase the fastest growth, driven by the rising population of the elderly, increasing incidence of SSIs, improving healthcare system, and adoption of improved products.